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Summary
 
By differential screening of tumor necrosis factor 
 
a
 
 (TNF-
 
a
 
) and lipopolysaccharide (LPS)-
activated endothelial cells (ECs), we have identified a cDNA clone that turned out to be a
member of the inhibitor of apoptosis (
 
iap
 
) gene family. 
 
iap
 
 genes function to protect cells from
undergoing apoptotic death in response to a variety of stimuli. These 
 
iap
 
 genes, 
 
hiap
 
1, 
 
hiap
 
2,
and 
 
xiap
 
 were found to be strongly upregulated upon treatment of ECs with the inflammatory
cytokines TNF-
 
a
 
, interleukin 1
 
b
 
, and LPS, reagents that lead to activation of the nuclear tran-
scription factor 
 
k
 
B (NF-
 
k
 
B). Indeed, overexpression of I
 
k
 
B
 
a
 
, an inhibitor of NF-
 
k
 
B, sup-
presses the induced expression of 
 
iap
 
 genes and sensitizes ECs to TNF-
 
a
 
–induced apoptosis.
Ectopic expression of one member of the human 
 
iap
 
 genes, human X-chromosome–linked 
 
iap
 
(
 
xiap
 
), using recombinant adenovirus overrules the I
 
k
 
B
 
a
 
 effect and protects ECs from TNF-
 
a
 
–
induced apoptosis. We conclude that 
 
xiap
 
 represents one of the NF-
 
k
 
B–regulated genes that
counteracts the apoptotic signals caused by TNF-
 
a
 
 and thereby prevents ECs from undergoing
apoptosis during inflammation.
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nuclear factor 
 
k
 
B
 
E
 
ndothelial cells (ECs) are located at the strategic inter-
face between blood stream and tissue and regulate local
exchange of cells and nutrients. They are critically involved
in local and systemic inflammatory responses at the sites of
transmigration of immune cells such as neutrophils, mono-
cytes, and lymphocytes. The concentration of inflamma-
tory cytokines at the site of transmigration is expected to be
high, and in fact inflammatory cytokine–mediated activa-
tion of ECs is responsible for the attraction, adhesion, and
extravasation of white blood cells to the inflamed tissue.
Stimulation of cells with TNF-
 
a
 
, a potent inflammatory
cytokine, generates two types of signals: one that initiates
programmed cell death (1), and one that leads to activation
of the transcription factor NF-
 
k
 
B (2), and subsequently to
the inflammatory response. The overall result in a specific
cell type is dependent on the balance of the two signals.
Direct inhibition of NF-
 
k
 
B or of the upstream parts of its
signaling pathway during TNF-
 
a
 
 activation results in apop-
tosis in a variety of cell types originally resistant to TNF-
 
a
 
–
induced apoptosis (3, 4). Furthermore, fibroblasts and mac-
rophages from NF-
 
k
 
B subunit p65–deficient mice are
more sensitive to TNF-
 
a
 
–induced apoptosis (5). There-
fore, it has been proposed that activation of NF-
 
k
 
B induces
the expression of genes that counteract apoptotic signals
and prevent cell death.
Members of the inhibitor of apoptosis (
 
iap
 
) gene family
have been demonstrated to suppress apoptosis induced by a
variety of stimuli in different cell types (6–13, and for re-
view see reference 14). The 
 
iap
 
 genes have also been
shown to play a role in TNF-
 
a
 
–induced programmed cell
death. Different 
 
iap
 
 gene family members appear to inter-
fere with the cell death–triggering cascade at different lev-
els. 
 
hiap
 
1 and 
 
hiap
 
2 can bind to the TNFR-associated factor
2 (TRAF2), a molecule that is associated with the cytoplas-
mic part of the TNFR complex and is essential for the acti-
vation of NF-
 
k
 
B (9, 15). Both have also been shown to be
direct inhibitors of cell death proteases caspase 3 and
caspase 7 (16). Another 
 
iap
 
 gene family member, the
X-chromosome–linked 
 
iap
 
 (
 
xiap
 
), protects embryonic kid-
ney 293T cells from bax-triggered apoptosis by inhibiting
the same proteases, but in contrast it has not been found to
be associated with members of the TRAF family (16, 17).
The studies presented here demonstrate that three hu-
man 
 
iap
 
 gene family members (
 
xiap
 
, 
 
hiap
 
1, and 
 
hiap
 
2) are
strongly upregulated in TNF-
 
a
 
–stimulated primary ECs,
which are resistant to TNF-
 
a
 
–induced apoptosis. How-
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ever, adenovirus-mediated overexpression of I
 
k
 
B
 
a
 
 (18,
19), an inhibitor of NF-
 
k
 
B, renders primary ECs sensitive
to TNF-
 
a
 
–induced apoptosis and at the same time inhibits
 
iap
 
 gene upregulation. Thus, 
 
iap
 
 gene expression appears to
be dependent on NF-
 
k
 
B activation. Importantly, we show
that ectopic expression of 
 
xiap
 
 is sufficient to overcome the
I
 
k
 
B
 
a
 
 effect in I
 
k
 
B
 
a
 
-overexpressing ECs and protects these
cells from TNF-
 
a
 
–induced apoptosis.
 
Materials and Methods
 
Cell Culture
 
Cell culture flasks were coated with 1% gelatine for 30 min at
37
 
8
 
C. Human umbilical vein endothelial cells (HUVECs) and
human skin microvascular endothelial cells (HSMECs) were
grown in medium M199 supplemented with 20% bovine calf se-
rum (HyClone, Logan, UT), endothelial cell growth factor sup-
plement (Technoclone, Vienna, Austria), penicillin, streptomy-
cin, fungizone, and heparin (3 U/ml). Confluent cells were split
in a 1:3 ratio and used up to the sixth passage.
U937 cells were cultivated in RPMI-1640 medium supple-
mented with 10% FCS, 
 
l
 
-glutamine, penicillin, and streptomy-
cin. Cells were split 1:10 when grown to a density of 10
 
6
 
 cells/ml.
 
Northern Analysis
 
Total RNA was isolated using Trizol reagent (GIBCO BRL,
Gaithersburg, MD). 10 
 
m
 
g total RNA was separated on a 1.3%
formaldehyde agarose gel. Samples were run in 0.02 M MOPS
(3-[N-morpholino]propanesulfonic acid), pH 7.0, 5 mM sodium ac-
etate, 1 mM EDTA. The gel was blotted overnight using 10
 
3
 
 SSC
onto a GeneScreen Plus nylon membrane (Dupont-NEN, Boston,
MA), dried, and fixed by UV-light (UV-cross-linker 120.000 
 
m
 
J;
Stratagene Inc., La Jolla, CA). Membranes were hybridized with
 
a
 
-[
 
32
 
P]dATP-labeled (Terminal Transferase, Boehringer Mannheim,
Mannheim, Germany) oligonucleotides specific to 
 
hiap
 
1 (5
 
9
 
-agaaat-
gtttcagtggcattcaatcaacccaaagatgtaatgtgtgactcatgaagcttct-3
 
9
 
), 
 
hiap
 
2 (5
 
9
 
-
aagatttccaccacaaaaagaaatcaatgatagactcttatgtagaatttactacactttc-3
 
9
 
),
 
xiap
 
 (5
 
9
 
-gaagggtggtgggtgggaaacaacacagctccctaggaagagcacaggatagtca-
cggggg-3
 
9
 
), and 
 
naip
 
 (5
 
9
 
-actgcatctaggcccagaagagcagacagctctggcagca-
aattgtgatcaaactgggaga-3
 
9
 
) using Quickhyb-solution (Stratagene, Inc.)
at 65
 
8
 
C. Membranes were washed twice for 15 min at room tem-
perature in 1% SDS/3
 
3
 
 SSC/20 mM sodium phosphate buffer,
pH 7.2, and twice for 30 min at 65
 
8
 
C in 1% SDS/1
 
3
 
 SSC. Sig-
nals were analyzed on a PhosphorImager SF (Molecular Dynam-
ics, Sunnyvale, CA).
 
Adenovirus Construction and Infection
 
Adenovirus I
 
k
 
B
 
a
 
 has been described previously (26), and con-
struction of 
 
xiap
 
 adenovirus was done by firstly introducing a
fragment encoding the myc peptide sequence MEQKLISEEDL
into the adenovirus transfer vector pACCMVpLpASR1 (20).
Subsequently, a 1,600-bp BamHI/XbaI cDNA fragment contain-
ing the entire coding region of human xiap was ligated and the
construct was cotransfected together with pJM17, a plasmid con-
taining the adenoviral genome with a deletion in the E1 region
into 293 cells (21). Plaques appearing after 10 d of culture were
subcloned on 293 cells and were tested for xiap expression on im-
munoblots using anti-myc mAb 9E10 (22). Purification of a large
batch of the recombinant adenovirus was done by two consecu-
tive cesium chloride centrifugations as previously described (23).
Postconfluent HSMECs and HUVECs were washed once
with complete PBS and incubated at a multiplicity of infection of
100 with the respective adenovirus constructs in PBS. After 30
min at 378C, the adenovirus was washed off and fresh medium
was added. Cells were maintained for an additional 2 d before be-
ing assayed.
Analysis of DNA Fragmentation
Electrophoresis of Genomic DNA. Cells were incubated for 3 h
at 558C (100 mM NaCl, 10 mM Tris Hcl, pH 8.0, 25 mM
EDTA, 0.5% SDS, 0.47 mg/ml Proteinase K), and then incu-
bated with 100 mg/ml RNAseA for 1 h at 378C. After phenol–
chloroform extraction and isopropanol precipitation, the DNA was
dissolved in 50 ml Tris/EDTA and resolved on 1.3% agarose gel.
Quantification of Fragmented DNA. For quantification of apop-
tosis fragmented DNA was determined by sandwich ELISA with
antihistone coated microtiter plates and peroxidase-conjugated
anti-DNA antibodies using the Cell Death Detection ELISA sys-
tem from Boehringer Mannheim, according to the manufac-
turer’s protocol.
Flow Cytometry
48 h after infection cells were treated with TNF-a (500 U/ml)
for 6 h or left untreated. Cells were harvested, fixed in 70% etha-
nol, and the proportion of cells undergoing apoptosis was deter-
mined by flow cytometric analysis (FACSortÒ, Becton Dickin-
son, San Jose, CA) after staining with propidium iodide. Cells
with a DNA content ,2 N appear in the sub-G1 region (M1).
Results and Discussion
Using a modified differential screening technique to
identify and clone genes regulated by inflammatory media-
tors in porcine aortic ECs (PAECs) (23a) we have obtained
a porcine homologue (piap) of the human iap gene family.
Initially identified as a TNF-a–inducible gene, piap was
found also to respond to the inflammatory stimuli LPS and
to a lesser degree to IL-1b. Subsequently, we have tested
whether members of the human iap gene family (xiap
[hILP, MIHA], hiap1 [ciap2, MIHC], and hiap2 [ciap1,
MIHB]; references 6–12) show similar responses to inflam-
matory cytokines. Using oligonucleotides specific for the
different iap genes, we performed Northern blot analysis of
HSMECs (Fig. 1) and HUVECs (data not shown). We
demonstrate that, apart from the neuronal inhibitor of apop-
tosis (naip) that is not expressed in ECs, the xiap, hiap1, and
hiap2 genes were strongly upregulated in response to TNF-a
in HSMECs and HUVECs.
Treatment of HSMECs or HUVECs with TNF-a for
up to 24 h did not lead to apoptosis, whereas the well-
established TNF-a–sensitive monocytic cell line U937 be-
came apoptotic under these experimental conditions. iap
gene expression has been shown to inhibit apoptosis in-
duced by a variety of apoptotic stimuli (12). Thus, we spec-
ulated that induced iap gene expression may prevent ECs
from undergoing programmed cell death in response to
TNF-a.
TNF-a is a proinflammatory cytokine whose pleiotropic
biological effects are signaled through two distinct cell sur-
face receptors, TNFR 1 and TNFR 2 (2). It is known to
be a potent activator of NF-kB that has been shown to be
the central mediator of gene regulation in the inflammatory213 Stehlik et al. Brief Definitive Report
response of activated ECs leading to leukocyte adhesion
and thrombosis (24, 25). Therefore, we tested whether
NF-kB was involved in upregulation of iap genes in re-
sponse to inflammatory stimuli. Having shown previously
that expression of IkBa from a recombinant adenovirus
vector abolishes NF-kB-dependent upregulation of inflam-
matory genes such as IL-1b, IL-6, IL-8, and vascular cell
adhesion molecule 1 in LPS-stimulated ECs (26), we used
this adenovirus-IkBa construct to investigate whether
NF-kB inhibition also impairs iap gene expression. HU-
VECs and HSMECs were infected with either a control
adenovirus or the recombinant adenovirus IkBa (27). After
2 d, cells were stimulated with TNF-a for 4 h and probed for
xiap, hiap1, and hiap2 expression. As shown in Fig. 2, the
expression of all three iap genes tested in adenovirus IkBa–
infected ECs was suppressed, indicating that the upregula-
tion of iap genes is controlled by activation of NF-kB.
We then raised the question whether blocking the acti-
vation of NF-kB would actually sensitize ECs to TNF-
a–induced apoptosis. Indeed, ECs infected with the re-
combinant adenovirus IkBa construct started to die z6 h
after TNF-a stimulation. To demonstrate that the apop-
totic program is involved in cell death, genomic DNA was
isolated from dying cells. As shown in Fig. 3, genomic
DNA from IkBa-expressing and TNF-a–treated cells, but
not from control virus–infected or nontreated cells, showed
the DNA fragmentation pattern characteristic for apoptosis.
Thus, inhibition of NF-kB activation renders ECs TNF-a
sensitive, indicating that induction of apoptosis in ECs can
occur independent of NF-kB.
These data suggested that TNF-a–induced expression of
iap genes could be required to protect ECs from undergo-
ing apoptosis. To directly demonstrate the ability of iap
genes to prevent ECs from TNF-a–induced apoptosis, we
coinfected HUVECs with recombinant adenovirus con-
structs expressing myc-tagged xiap and IkBa, respectively.
Infection with recombinant adenovirus IkBa alone and
stimulation with TNF-a–induced apoptosis in HUVECs
(Fig. 4 B, c and d). Coexpression of xiap and IkBa (Fig. 4
B, f ) reduced the percentage of apoptotic cells to back-
ground levels obtained in TNF-a–treated or nontreated
HUVECs (Fig. 4 B, a and b). A recombinant adenovirus
expressing green fluorescent protein (27) was used as a con-
trol to show that adenovirus infection itself had no influ-
ence on apoptosis induced by TNF-a in IkBa-overex-
pressing cells (Fig. 4 B, g and h). Expression of myc-tagged
xiap in infected HUVECs was demonstrated by Western
blots stained with anti-myc mAb (Fig. 4 A).
Since the monocytic cell line U937 is sensitive to TNF-
a–induced apoptosis when compared to primary ECs, we
analyzed whether this cell line also differs with respect to
TNF-a–inducible upregulation of iap genes. U937 and
HUVECs were treated with TNF-a for 4, 6, and 9 h. At
the same time points we monitored and quantified apopto-
sis by analysis of fragmented genomic DNA using an
ELISA assay for histone-associated DNA fragments. Fig. 5
C shows that xiap gene was barely expressed in nontreated
U937 cells and expression could not be induced by TNF-a.
Consistently, U937 cells became significantly apoptotic af-
ter 4 h (Fig. 5 D). In contrast, as shown in Fig. 5, A and B,
xiap was upregulated in HUVECs and no increase in frag-
mented DNA could be assayed in response to TNF-a.
Identical results were obtained for hiap1 and hiap2 in U937
cells and HSMECs (data not shown).
Figure 1. Northern blot anal-
ysis of iap gene expression in
HSMECs. 10 mg of total RNA
from either nontreated or TNF-
a–treated (500 U/ml) HSMECs
was loaded in each lane and hy-
bridized to oligonucleotides spe-
cific to hiap1, hiap2, xiap, and
naip. The predicted transcript
size corresponds to the published
one (7) for hiap1 (6.5 kb), hiap2
(4.5 kb), and xiap (9 kb). To con-
firm the equal loading of RNA,
membranes were stripped and
reprobed with GAPDH.
Figure 2. Northern blot anal-
ysis of iap gene expression in ad-
enovirus IkBa–infected ECs.
HUVECs and HSMECs were
not infected, were infected with
a control adenovirus, or were in-
fected with the recombinant ad-
enovirus IkBa construct. Cells
were either left untreated or
treated with TNF-a (500 U/
ml) for 4 h. The membranes
were probed with oligonucle-
otides specific to hiap1, hiap2,
and  xiap. Expression of IkBa was
controlled by reprobing the mem-
branes with an IkBa-cDNA.
Equal loading was confirmed by
hybridization with a GAPDH
cDNA probe. Adv, adenovirus.
Figure 3. DNA fragmentation
in adenovirus IkBa–infected and
TNF-a–stimulated HUVECs.
HUVECs were not infected,
were infected, with a control ad-
enovirus, or were infected with
the recombinant adenovirus-
IkBa construct. Noninfected
cells and infected cells were left
untreated or treated with TNF-a
(500 U/ml) for 6 h. Appearance
of fragmented genomic DNA
was analysed by 1.3% agarose gel
electrophoresis. Left lane: 1-kb
ladder molecular weight stan-
dard; right lane: 123-bp ladder
molecular weight standard. Non-
inf.: noninfected cells; AdV: ade-
novirus.214 NF-kB–regulated xiap Protects ECs from TNF-a–induced Apoptosis
Our findings provide several lines of evidence that the
iap gene products are regulated by NF-kB and that xiap ap-
pears to be sufficient to protect primary ECs from under-
going apoptosis in response to TNF-a: (a) iap genes are ex-
pressed in response to TNF-a, IL-1b, and LPS, respectively;
(b) inhibition of NF-kB activation suppresses inducible iap
gene expression; (c) inhibition of NF-kB activation by
overexpressing its inhibitor IkBa renders ECs sensitive to
TNF-a–induced apoptosis; and (d) ectopic expression of
xiap in IkBa-overexpressing ECs overrules the IkBa/
TNF-a effect.
These data show that ECs and presumably other cells
have developed cellular mechanisms that protect them
from apoptosis and keep them able to function properly in
an inflammatory situation. Fast activation of NF-kB in re-
sponse to proinflammatory signals, like TNF-a, would be
an appropriate mechanism to ensure the prompt expression
of antiapoptotic gene(s). This hypothesis is supported by
the demonstration that NF-kB p65 is necessary to protect
fibroblasts from TNF-a–induced apoptosis (5).
Whether under physiological circumstances the expres-
sion of xiap is sufficient or whether simultanous expression
of all three iap genes (or other genes such as A20 [28], man-
ganese superoxide dismutase [29], plasminogen activator–
inhibitor type 2 [30], A1 [31], or other as yet undefined
genes) is required to protect ECs from TNF-a–induced
apoptosis remains open. Chu et al. (32) have shown re-
cently that hiap1 expression is dependent on activation of
NF-kB in Jurkat cells and hiap1 protein is able to protect
these cells from apoptosis. However, in contrast to primary
ECs, hiap2 showed a steady state level of expression in Jur-
kat cells and was not controlled by NF-kB. The data indi-
cate that expression of the iap gene family members and
their involvement in protection from apoptosis varies in
certain cell types and follows a rather complex scheme. iap
gene expression appears to be specific for the cell type and
the given stimulus. This view is supported by our finding
that iap gene expression seems to be not involved in the
TNF-a response of the monocytic cell line U937. These
cells become partially apoptotic upon TNF-a treatment
but do not express iap genes, suggesting that other protec-
tive mechanisms are operative. Recent reports demon-
strated that hiap1/2 can interfere at different levels with the
apoptotic program. hiap1 and hiap2 associate via TRAF 2
Figure 4. Inhibition of apoptosis by ectopic xiap expression. (A) Lysates of noninfected or infected HUVECs were separated by SDS-PAGE, blotted
onto nylon membranes, and stained for myc-tagged XIAP protein. AdV, adenovirus; GFP, green fluorescent protein. (B) HUVECs were infected with
IkBa alone (c and d), together with xiap (e and f ), or together with GFP (g and h) recombinant adenovirus. 48 h after infection cells were treated with
TNF-a (500 U/ml) for 6 h or left untreated and analyzed by FACSÒ after propidium iodide staining. Cells with a DNA content ,2 N appear in the
sub-G1 region (M1). The percentage of cells found in the M1 region is indicated. The data show one out of three representative experiments.
Figure 5. Lack of TNF-a–inducible xiap gene expression correlates
with apoptosis in U937 cells. Northern blot analysis of xiap gene expres-
sion in HUVECs (A) and U937 cells (C). HUVECs and U937 cells were
treated for 4, 6, and 9 h with TNF-a. To confirm equal loading of RNA,
membranes were stripped and reprobed with GAPDH. TNF-a–induced
genomic DNA fragments from HUVECs (B) and U937 cells (D) were
determined by colorimetric enzyme immunoassay. Columns represent the
mean of three independent experiments. SD is indicated by error bars.
TNF-a (500 U/ml); c, nontreated cells.215 Stehlik et al. Brief Definitive Report
with the TNFR 2, leading to NF-kB activation (9), and
hiap2 is also part of the TNFR 1 signaling complex (15).
On the other hand, hiap1 and hiap2 as well as xiap directly
inhibit caspase 3 and caspase 7 activity, two members of the
caspase family of cell death proteases, in embryonic kidney
293T cells (16, 17). However, inhibition by xiap is two to
three orders of magnitude more potent, suggesting xiap as
the physiological inhibitor of caspase 3 and 7 (16). These
data and our finding that xiap expression is sufficient to
prevent TNF-a–induced apoptosis in ECs support the
concept that xiap plays a central role in inhibition of pro-
grammed cell death. It remains to be established whether
xiap operates via an identical mechanism in ECs as in 293T
cells and which other cell-type specific and stimulus-
dependent mechanisms exist.
Unexpectedly,  iap gene expression is also induced by
LPS and IL-1b. Pretreatment of a human fibrosarcoma line
(HT1080V) with the nonapoptotic, NF-kB–inducing IL-1
protects these cells from apoptosis induced by the later ad-
dition of TNF-a even in the presence of a protein synthesis
inhibitor (3). In cells expressing a super-repressor form of
the NF-kB inhibitor IkBa, IL-1b does not have this pro-
tective effect, suggesting that IL-1b also induces the ex-
pression of NF-kB–regulated antiapoptotic genes. A mech-
anism to overrule apoptotic signals during inflammation
would enable ECs to respond properly by upregulation of
inflammatory mediators such as tissue factor and adhesion
molecules and at the same time to survive inflammation in
order to maintain homeostasis of the inflamed tissue and
initiate the healing process.
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